Chemotherapy combined with regorafenib and immune checkpoint inhibitors as a first-line treatment for patients with advanced biliary tract cancer: a single arm phase II trial

ObjectiveThis study aimed to investigate the efficacy, long-term prognosis and safety of combining chemotherapy with regorafenib and immune checkpoint inhibitors as first-line treatment for patients with advanced biliary tract carcinoma (BTC).MethodsIn this single arm phase II trial, twenty-nine pat...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Jianwei Liu, Shilei Bai, Yanfu Sun, Lei Hu, Ruiliang Ge, Feng Xue
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-09-01
Subjects:	advanced biliary tract cancer first-line therapy targeted therapy immunotherapy chemotherapy prognosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1449211/full